Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centerpulse was a prominent Swiss medical technology company that specialized in the development and manufacture of orthopedic, spinal, and dental implants. Formerly known as Sulzer Medica, the company established itself as a leader in the European reconstructive joint market, offering a wide range of products for hip, knee, and shoulder replacement. In the early 2000s, Centerpulse navigated a significant restructuring and legal settlement following a major recall of hip and knee components. Its strong market presence and innovative technology portfolio made it a key acquisition target, leading to its purchase by Zimmer Holdings in 2003 for approximately $3.2 billion. The integration of Centerpulse significantly expanded Zimmer's global footprint and product offerings in the musculoskeletal healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centerpulse.